PMID- 31894344 OWN - NLM STAT- MEDLINE DCOM- 20200821 LR - 20211112 IS - 1791-2431 (Electronic) IS - 1021-335X (Linking) VI - 43 IP - 2 DP - 2020 Feb TI - Effect of CUL4A on the metastatic potential of lung adenocarcinoma to the bone. PG - 662-670 LID - 10.3892/or.2019.7448 [doi] AB - Cullin 4A (CUL4A) is a member of the cullin family of proteins and has been demonstrated to be abnormally expressed in various types of malignancies. However, the function of CUL4A in metastasis of lung adenocarcinoma to the bone has rarely been reported. The aim of present of the study was to explore the biological functions and potential underlying molecular mechanisms of CUL4A in lung adenocarcinoma, highlighting a novel therapeutic target for the diagnosis and treatment of patients with lung adenocarcinoma. A549‑CUL4A, H1299‑CUL4A and H460‑shCUL4A cells were created using lentiviral infection. The efficiency of knockdown or overexpression was assessed using reverse transcription‑quantitative PCR and western blotting. The effects of CUL4A on proliferation, migration and invasion of lung adenocarcinoma cells in vitro and metastasis to the bone in vivo were determined using an MTT assay, colony formation assay, wound‑healing assay, Transwell assay and a mouse model of bone metastasis. The relationship between CUL4A and the EMT‑activator zinc finger E‑box binding homeobox 1 (ZEB1) were detected by western blotting. The results showed that overexpression of CUL4A in lung adenocarcinoma cells increased proliferation, migration and invasion, and increased metastasis of A549 to the bones in vivo. Silencing of CUL4A expression in lung adenocarcinoma cells reduced proliferation, migration and invasion in vitro. Mechanistically, CUL4A transcriptionally upregulated expression of ZEB1 which resulted in epithelial‑mesenchymal transition, which in turn promoted metastasis of lung adenocarcinoma to the bones. Taken together, these results suggest that CUL4A may serve an important regulatory role in the development of metastasis of lung adenocarcinoma to the bone. FAU - Cao, Pei-Pei AU - Cao PP AD - Department of Oncology, Tangdu Hospital, The Air Force Medical University, Xi'an, Shaanxi 710038, P.R. China. FAU - Chen, Wen-Juan AU - Chen WJ AD - Department of Oncology, Tumor Hospital of Shaanxi Province, Xi'an, Shaanxi 710061, P.R. China. FAU - Pang, Hai-Lin AU - Pang HL AD - Department of Oncology, Tangdu Hospital, The Air Force Medical University, Xi'an, Shaanxi 710038, P.R. China. FAU - Shen, Wei-Wei AU - Shen WW AD - Department of Oncology, Tangdu Hospital, The Air Force Medical University, Xi'an, Shaanxi 710038, P.R. China. FAU - Xue, Peng AU - Xue P AD - Department of Orthopedics, Honghui Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi 710054, P.R. China. FAU - Duan, Lian AU - Duan L AD - Department of Oncology, Tangdu Hospital, The Air Force Medical University, Xi'an, Shaanxi 710038, P.R. China. FAU - Xu, Yu-Xuan AU - Xu YX AD - Department of Oncology, Tangdu Hospital, The Air Force Medical University, Xi'an, Shaanxi 710038, P.R. China. FAU - Liu, Li-Li AU - Liu LL AD - Department of Oncology, Tangdu Hospital, The Air Force Medical University, Xi'an, Shaanxi 710038, P.R. China. FAU - Zhang, He-Long AU - Zhang HL AD - Department of Oncology, Tangdu Hospital, The Air Force Medical University, Xi'an, Shaanxi 710038, P.R. China. LA - eng PT - Journal Article DEP - 20191227 PL - Greece TA - Oncol Rep JT - Oncology reports JID - 9422756 RN - 0 (CUL4A protein, human) RN - 0 (Cullin Proteins) RN - 0 (ZEB1 protein, human) RN - 0 (Zinc Finger E-box-Binding Homeobox 1) SB - IM MH - A549 Cells MH - Adenocarcinoma of Lung/genetics/metabolism/*pathology MH - Animals MH - Bone Neoplasms/genetics/metabolism/*pathology/*secondary MH - Cell Line, Tumor MH - Cell Movement MH - Cell Proliferation MH - Cullin Proteins/*genetics/*metabolism MH - Epithelial-Mesenchymal Transition MH - Female MH - Gene Expression Regulation, Neoplastic MH - Humans MH - Lung Neoplasms/genetics/metabolism/*pathology MH - Mice MH - Neoplasm Transplantation MH - Up-Regulation MH - Zinc Finger E-box-Binding Homeobox 1/*genetics OTO - NOTNLM OT - CUL4A OT - cullin 4A OT - lung adenocarcinoma OT - ZEB1 OT - epithelial-mesenchymal transition OT - bone metastasis EDAT- 2020/01/03 06:00 MHDA- 2020/08/22 06:00 CRDT- 2020/01/03 06:00 PHST- 2019/06/28 00:00 [received] PHST- 2019/11/27 00:00 [accepted] PHST- 2020/01/03 06:00 [pubmed] PHST- 2020/08/22 06:00 [medline] PHST- 2020/01/03 06:00 [entrez] AID - 10.3892/or.2019.7448 [doi] PST - ppublish SO - Oncol Rep. 2020 Feb;43(2):662-670. doi: 10.3892/or.2019.7448. Epub 2019 Dec 27.